1. Home
  2. RDHL vs MFI Comparison

RDHL vs MFI Comparison

Compare RDHL & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MFI
  • Stock Information
  • Founded
  • RDHL 2009
  • MFI 2002
  • Country
  • RDHL Israel
  • MFI Hong Kong
  • Employees
  • RDHL N/A
  • MFI 31
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MFI
  • Sector
  • RDHL Health Care
  • MFI
  • Exchange
  • RDHL Nasdaq
  • MFI NYSE
  • Market Cap
  • RDHL 8.2M
  • MFI 9.9M
  • IPO Year
  • RDHL N/A
  • MFI 2024
  • Fundamental
  • Price
  • RDHL $5.95
  • MFI $0.73
  • Analyst Decision
  • RDHL
  • MFI
  • Analyst Count
  • RDHL 0
  • MFI 0
  • Target Price
  • RDHL N/A
  • MFI N/A
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • MFI 329.2K
  • Earning Date
  • RDHL 08-29-2024
  • MFI 02-19-2025
  • Dividend Yield
  • RDHL N/A
  • MFI N/A
  • EPS Growth
  • RDHL N/A
  • MFI N/A
  • EPS
  • RDHL N/A
  • MFI N/A
  • Revenue
  • RDHL $3,707,000.00
  • MFI $3,877,747.00
  • Revenue This Year
  • RDHL $224.90
  • MFI N/A
  • Revenue Next Year
  • RDHL $82.69
  • MFI N/A
  • P/E Ratio
  • RDHL N/A
  • MFI N/A
  • Revenue Growth
  • RDHL N/A
  • MFI N/A
  • 52 Week Low
  • RDHL $5.41
  • MFI $0.51
  • 52 Week High
  • RDHL $20.28
  • MFI $14.49
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 39.54
  • MFI N/A
  • Support Level
  • RDHL $5.76
  • MFI N/A
  • Resistance Level
  • RDHL $6.26
  • MFI N/A
  • Average True Range (ATR)
  • RDHL 0.32
  • MFI 0.00
  • MACD
  • RDHL 0.01
  • MFI 0.00
  • Stochastic Oscillator
  • RDHL 18.85
  • MFI 0.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

Share on Social Networks: